New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 3, 2013
05:11 EDTVRXValeant provides efinaconazole update
Valeant Pharmaceuticals (VRX) announced the following update regarding efinaconazole: "We agreed this afternoon that the launch of efinaconazole, our topical product candidate for the treatment of onychomycosis, will not occur until after the September arbitration hearing to resolve the breach of contract dispute with Anacor Pharmaceuticals (ANAC). As a result, the preliminary injunction hearing which was scheduled for May 6-8, has been canceled. Valeant intends to vigorously contest Anacor's claims and continues to expect to launch the product in 2013.
News For VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:53 EDTVRXAckman says 'will take hard look' at Valeant shares after restrictions end
Subscribe for More Information
December 9, 2014
09:31 EDTVRXZoetis drops after report of Valeant abandoning growth by acquisitions strategy
Subscribe for More Information
06:39 EDTVRXValeant to abandon growth by acquisitions strategy, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use